Huxley Medical, a commercial-stage medical technology firm focused on streamlining detection of sleep and heart disorders, announced that the clinical validation study of its SANSA home sleep apnea ...

Fat jabs aside, losing body fat requires concerted effort. Exercise alone will not shift excess kilos – a diet and workout ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company focused on developing therapies for diseases ...

CRANFORD, N.J., June 17, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR ), the oncology-focused subsidiary of Citius Pharmaceut ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced ...

To boost mood and manliness, men are spending lots of money on the hormone testosterone—yet they may see trouble instead of ...

Ventyx Biosciences (NASDAQ:VTYX) announced Tuesday that a small mid-stage trial for VTX3232, its experimental therapy for Parkinson’s disease, reached the primary endpoint related to safety and ...

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated ...